127306-47-2

Upstream product

• 58479-61-1 tert-butylchlorodiphenylsilane 
• 51255-17-5 1-O-methyl-2-deoxy-D-ribofuranoside 
• 288-32-4 1H-imidazole 
• 22900-10-3 2-deoxy-D-ribose 

Downstream Products

• 183075-06-1 (2R,3S)-2-(tert-Butyl-diphenyl-silanyloxymethyl)-5-phenylsulfanyl-tetrahydro-furan-3-ol 
• 114071-61-3 methyl 5-O-(tert-butyldiphenylsilyl)-2-deoxy-3-O-(trifluoromethanesulfonyl)-α-D-erythro-pentofuranoside 
• 114071-61-3 methyl 5-O-(tert-butyldiphenylsilyl)-2-deoxy-3-O-(trifluoromethanesulfonyl)-β-D-erythro-pentofuranoside 
• 139212-94-5 Methanesulfonic acid (2R,3S,5S)-2-(tert-butyl-diphenyl-silanyloxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 
• 139212-95-6 5'-O-tert-butyldiphenylsilyl-3'-O-methanesulfonylthymidine 

Relevant academic research and scientific papers

Synthesis of erythro and threo furanoid glycals from 1- and 2-phenylselenenyl-carbohydrate derivatives

Differently protected erythro and threo furanoid glycals were synthesized by selenoxide elimination when phenyl 1-selenoglycosides were treated in oxidizing conditions (tBuOOH, Ti(OiPr)4, Et2iPrN). Th

Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine

Ethyl 2-alkyl-4-aryl-3-oxobutyrates were synthesized from the corresponding arylacetonitriles and 2-brome esters. Condensation of the butyrates with thiourea followed by treatment with chloroacetic acid afforded the 5-alkyl-6-(arylmethyl)uracils. Condensa

Pyrimidine intermediates

The present invention is directed to compounds of formula (I), STR1 wherein R1 is OH, NH2 ; R2 is a heteroaromatic or aromatic substituent; R3 is H, OH, F, OCH3 ; R4 is H, F, OH or an ether

Efficient Procedure for the Synthesis of Erythro and Threo Furanoid Glycals from 2-Deoxyribose

Differently protected erythro and threo furanoid glycals have been synthesised starting from 2-deoxyribose, via selenoxide elimination as the key step.